Cargando…
Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
BACKGROUND. The risk of infection associated with specific treatments of chronic active antibody-mediated rejection (cAMR) after kidney transplantation remains unknown. METHODS. This was a single-center study of kidney transplant recipients treated with pulse steroids, intravenous immunoglobulin (IV...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738046/ https://www.ncbi.nlm.nih.gov/pubmed/33335983 http://dx.doi.org/10.1097/TXD.0000000000001080 |